WASHINGTON, Aug. 30, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today the completion of its acquisition of Aldevron. As previously announced, Aldevron will operate as a standalone operating company and brand within Danaher’s Life Sciences segment.
ABOUT DANAHER
Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher’s globally diverse team of approximately 69,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life’s Potential. For more information, please visit www.danaher.com.
SOURCE Danaher Corporation
For further information: DANAHER CONTACT: Matthew E. Gugino, Vice President, Investor Relations and FP&A, Danaher Corporation, 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, D.C. 20037, Telephone: (202) 828-0850, Fax: (202) 828-0860